Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Flow Nasal Cannula Therapy as an Adjuvant in the Treatment of Severe Sepsis. A Multicenter Parallel-group Randomized Clinical Trial

NCT03334227 is registered in ClinicalTrials.gov with Althaia Xarxa Assistencial Universitària de Manresa as lead sponsor.

NCT NCT03334227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03334227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Flow Nasal Cannula Therapy as an Adjuvant in the Treatment of Severe Sepsis. A Multicenter Parallel-group Randomized Clinical Trial
Lead sponsor
Althaia Xarxa Assistencial Universitària de Manresa
Phase
Not applicable
Overall status
Terminated
Start date
January 8, 2018
Completion date
December 28, 2020
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis